Incidence, clinical findings, and survival of hepatosplenic T-cell lymphoma in the United States

Am J Hematol. 2017 Jun;92(6):E99-E101. doi: 10.1002/ajh.24711. Epub 2017 Apr 29.

Authors

Urshila Durani¹, Ronald S Go^{2

3}

Affiliations

¹ Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
² Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
³ Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA.

PMID: 28263402
DOI: 10.1002/ajh.24711

No abstract available

Publication types

Letter

MeSH terms

Adult
Ethnicity / statistics & numerical data
Female
Humans
Incidence
Income
Insurance Coverage
Liver Neoplasms / epidemiology*
Liver Neoplasms / pathology
Liver Neoplasms / therapy
Lymphoma, T-Cell / epidemiology*
Lymphoma, T-Cell / pathology
Lymphoma, T-Cell / therapy
Male
Morbidity / trends
Prognosis
Splenic Neoplasms / epidemiology*
Splenic Neoplasms / pathology
Splenic Neoplasms / therapy
Stem Cell Transplantation / statistics & numerical data
Survival Rate
Travel
United States / epidemiology